“The #1 longevity hack is ‘don’t be poor’” — Kara Swisher is a health economist
In full transparency, I’ve been a fangirl of Kara Swisher since I first read her work with Walt Mossberg and Recode, coinciding with my own work on the early adoption…
April 2026
Healthy Diets Linked to Higher Lung Cancer Risk in Youth
New USC research finds non-smoking adults under 50 who eat more fruits, vegetables and whole grains may face a higher risk of early-onset lung cancer
STAT+: The race to catch KRAS, pancreatic cancer’s ‘greasy ball,’ and create the most promising drug in decades
Daraxonrasib, a pancreatic cancer drug from Revolution Medicines, is showing unprecedented success. For patients like Leanna Stokes, survival time doubled.
How PR Influences What AI Says About Your Healthcare Brand
In this week’s podcast, Stewart Gandolf talks with Kelsey Kloss about why PR has become even more valuable in the AI era—and how healthcare brands can use earned media, press…
Muglin Eco-Retreat Advances Inclusive Tourism in Nepal
A two-day eco-retreat in Muglin brought together over 100 participants to promote inclusive tourism for persons with disabilities across Nepal
STAT+: FDA eyes expanding testosterone therapy for libido
New research questions GLP-1's purpose, a pancreatic cancer breakthrough, and more biotech news from The Readout
A Unified Sense of Self
By MIKE MAGEE Stanford neuroscientist, David Eagleman, reminded us this week that “A coherent explanation of consciousness eludes modern science.” That was his opening line in the New York Times…
The New Era of DIY Healthcare – The State of Consumer Healthcare is Buoyant, Empowering, and Holistic, from Head to Gut to Wallet
Consumers’ spending on healthcare, beyond a health insurance premium and hospital bills, is among the fastest-growing industries in the U.S. — with spending increasing faster than overall retail, Circana’s tracking…
Undervalued to In-Demand: Rethinking Incentives in Primary Care
A consistent pattern in medical training is hard to ignore: many students enter wanting to work in primary care with underserved groups, yet later choose to pursue specialty careers. I’d…
STAT+: Cochrane review reignites Alzheimer’s amyloid wars
Another Elevidys trial, FDA reconsiders peptides, and other biotech news from The Readout